about
Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic reviewFocus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsBesifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial InfectionsInterplay in the selection of fluoroquinolone resistance and bacterial fitnessUnexpected link between an antibiotic, pannexin channels and apoptosisAntibiotic Prescriptions and Prophylaxis in Italian Children. Is It Time to Change? Data from the ARPEC Project.Systemic use of fluoroquinolone in children.Prulifloxacin: a new antibacterial fluoroquinolone.Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacinCumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy.Activity of quinolone CP-115,955 against bacterial and human type II topoisomerases is mediated by different interactions.A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics?Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats.Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV.Antibacterial properties of the CFTR potentiator ivacaftor.Environmental phosphate differentially affects virulence phenotypes of uropathogenic Escherichia coli isolates causative of prostatitis.Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance.CIPROFLOXACIN RESISTANCE PATTERN AMONG BACTERIA ISOLATED FROM PATIENTS WITH COMMUNITY-ACQUIRED URINARY TRACT INFECTIONFluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical IsolatesA "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.Characteristics of Quinolone Resistance in Escherichia coli Isolates from Humans, Animals, and the Environment in the Czech Republic10 years' experience with the pneumococcal quinolone moxifloxacin.Mechanism of quinolone action and resistance.Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review.Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance.Molecular biology of drug resistance in Mycobacterium tuberculosisApproach to antimicrobial prophylaxis for urology procedures in the era of increasing fluoroquinolone resistance.Antibiotic resistance in Staphylococcus aureus. Current status and future prospects.Synthesis of first ever 4-quinolone-3-carboxylic acid-appended spirooxindole-pyrrolidine derivatives and their biological applications.Design, Synthesis and Antibacterial Evaluation of Some New 2-Phenyl-quinoline-4-carboxylic Acid Derivatives.Preparation of Thermosensitive Gel for Controlled Release of Levofloxacin and Their Application in the Treatment of Multidrug-Resistant Bacteria.Antibiotic resistance mechanisms in M. tuberculosis: an update.Targeting bacterial topoisomerases: how to counter mechanisms of resistance.Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.Two fluoroquinolones and their combinations with hyaluronan: comparison of effects on canine chondrocyte culture.
P2860
Q26741887-E3F5DD59-69B4-4718-A8F3-352CE506DB7CQ26746197-339EA6DC-C630-4B58-95B7-2CC3C77575AEQ26752242-F0331009-E335-4E9A-9718-03DE0C58CAFDQ28475870-F66414C8-DF8C-4196-90C4-26C1CE20D0A2Q30410630-27822B75-8638-4719-86F5-156DDB210553Q31096335-165A7427-6791-40BB-A02F-3DF647E0C63AQ34349032-064C633C-95C4-45DB-9F30-C34CF7075F20Q34564526-313BA7D3-0FB0-4B3E-A127-D97CF85F66E6Q34941542-20F01BF2-E033-4FE3-871B-21B8981E33EFQ35374935-43E78C97-A248-4AAA-B8BA-3C3AF5BA56A1Q35547748-2B2F5409-EE95-469A-B046-9C7604C994AAQ35592636-D82E59DB-2809-41F1-96F6-8527F1C25939Q35617587-D2B487DA-D293-40E6-ADBF-D76D44D3BD59Q35626961-A519491F-F247-4EB3-9108-7D119D979C76Q35682214-D85F44C2-E4CB-419F-BC2A-0C736921E88FQ35844527-CA235D57-63A1-4D64-94EC-882843E1CC27Q36479059-AB641B1F-494C-4970-948F-2A25A283C8D0Q36483013-C1D1080F-DEBC-4C3C-A7C6-6695FD55BC22Q36607348-05AAFC67-BE96-4E4F-B2A2-2282C8A71E95Q36783606-984B0A38-5AA3-4C17-A7B9-5A9C3DBD5ABBQ37134169-CC949BF7-AA38-492B-8FA2-9154F6CC05ECQ37191156-3E869DD9-6C84-4353-B199-7693A4F48AFEQ37203798-5C704C33-62CD-4102-BBE8-E62EFC7A967AQ37204002-586555C7-200A-4C5B-B2EA-1F5613D6706DQ37407949-723CFB8C-1EBA-435D-A0C3-9CFF26410B76Q37570567-2632AC6A-79ED-4998-A27D-98F8A3DED12CQ37579919-FDD1D410-DF43-4C6D-9EB8-FCFF9E0D62E5Q37701591-03B6A927-513B-44F8-8C88-AB7D817D2496Q37982661-253ABC7A-6893-4EEE-A488-94066FCA9109Q38009935-A53E6767-DBC6-436B-87C3-C261D6A6964DQ38062402-90CA8419-70CC-4E39-9EFA-E7B0AF81F6C7Q38176343-950D57DD-6CB7-467C-BB09-BB26329F764BQ38728885-4F06B944-0616-4E9F-84F6-0EA498629805Q38743645-5C20B91F-70B1-41E1-9818-D23815065986Q38786216-0B0EEE71-28FB-418E-8DD5-46DF596C0788Q38816087-8F891CA6-DE3E-4068-95B3-5B7D0A2949CFQ38830420-BEEDA5C5-8B7D-4AD9-AD91-C1D1EC16CD6BQ38855273-80D0CB2F-092B-43F3-9039-6D1F6D39CC0DQ40066337-7ABC1BCC-DE95-4644-9E22-852B41E9440DQ40758206-C92079C5-5CDA-4A51-920A-7BF090E3CBC5
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The quinolones: past, present, and future.
@ast
The quinolones: past, present, and future.
@en
type
label
The quinolones: past, present, and future.
@ast
The quinolones: past, present, and future.
@en
prefLabel
The quinolones: past, present, and future.
@ast
The quinolones: past, present, and future.
@en
P2860
P356
P1476
The quinolones: past, present, and future.
@en
P2093
Vincent T Andriole
P2860
P304
P356
10.1086/428051
P407
P478
41 Suppl 2
P577
2005-07-01T00:00:00Z